Literature DB >> 24332301

Prevention of cervical cancer in Central and Eastern Europe and Central Asia: a challenge for the future.

Vesna Kesic1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24332301     DOI: 10.1016/j.vaccine.2012.11.105

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  5 in total

Review 1.  Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.

Authors:  Ana Gradíssimo; Robert D Burk
Journal:  Expert Rev Mol Diagn       Date:  2017-02-20       Impact factor: 5.225

2.  Cervical Cancer Mortality in East-Central European Countries.

Authors:  Cezary Wojtyla; Michal Ciebiera; Dariusz Kowalczyk; Grzegorz Panek
Journal:  Int J Environ Res Public Health       Date:  2020-06-28       Impact factor: 3.390

Review 3.  Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing.

Authors:  Yubo Fan; Yifan Meng; Shuo Yang; Ling Wang; Wenhua Zhi; Cordelle Lazare; Canhui Cao; Peng Wu
Journal:  Dis Markers       Date:  2018-11-14       Impact factor: 3.434

Review 4.  Gavi HPV Programs: Application to Implementation.

Authors:  Celina M Hanson; Linda Eckert; Paul Bloem; Tania Cernuschi
Journal:  Vaccines (Basel)       Date:  2015-05-20

5.  Cervical Cancer Mortality in Romania: Trends, Regional and Rural-Urban Inequalities, and Policy Implications.

Authors:  Florentina Furtunescu; Roxana Elena Bohiltea; Adrian Neacsu; Corina Grigoriu; Corina Silvia Pop; Nicolae Bacalbasa; Ionita Ducu; Ana-Maria Iordache; Radu Virgil Costea
Journal:  Medicina (Kaunas)       Date:  2021-12-23       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.